Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., is the Mescal Swaim Ferguson Distinguished Professor and director of the Center for Nanotechnology in Drug Delivery at the UNC Eshelman School of Pharmacy and codirector of the Carolina Institute for Nanomedicine at the University of North Carolina at Chapel Hill. Prior to joining UNC-Chapel Hill in July 2012, Kabanov served for nearly eighteen years at the University of Nebraska Medical Center where he was the Parke-Davis Professor of Pharmaceutical Sciences and director of the Center for Drug Delivery and Nanomedicine, which he founded in 2004. Kabanov received his PhD in chemical kinetics and catalysis in 1987 at Moscow State University, USSR.
Kabanov has conducted pioneering research on polymeric micelles, DNA/polycation complexes, block ionomer complexes and nanogels for delivery of small drugs, and nucleic acids and proteins that have influenced considerably current ideas and approaches in drug delivery and nanomedicine. His work led to the first-in-man polymeric micelle drug (SP1049C) to treat cancer, which successfully completed Phase II clinical trial and is under further evaluation. He cofounded Supratek Pharma, Inc. (Montreal, Canada), which develops therapeutics for cancer, and Neuro10-9, Inc. (Omaha, Nebraska, and Chapel Hill, North Carolina), which focuses on diseases of the central nervous system.
Kabanov has published more than 240 scientific papers and has more than 100 patents worldwide. His work has been cited over 22,000 times (Hirsch index 81) and he was named the Thomson Reuters 2014 Highly Cited Researcher in pharmacology and toxicology. His cumulative research support in academia as principal investigator has been more than $54 million. His inventions have attracted nearly $60 million in private, foundation, and company-sponsored R&D funding in industry. He founded the ongoing Nanomedicine and Drug Delivery Symposium series in 2003, co-chaired the Gordon Research Conference on Drug Carriers in Medicine and Biology in 2006, was vice-chair of the Gordon Research Conference on Cancer Nanotechnology in 2015, and is the chair elect of this conference in 2017.
Kabanov received the Lenin Komsomol Prize in 1988, an NSF Career Award in 1995, the University of Nebraska ORCA Award in 2007, and the University of Nebraska Medical Center Scientist Laureate in 2009, among other distinctions. He is also the recipient of a Russian Megagrant (2010). In 2013, he was elected as a member of Academia Europaea.
Kabanov was director of the Nebraska Center for Nanomedicine, an NIH Center of Biomedical Research Excellence, from 2008 to 2012 and is a director of the Moscow State University Laboratory of Chemical Design of Bionanomaterials, which he founded at in 2010 with Megagrant support. In 2015 he became a director of the Carolina Cancer Nanotechnology Training program.
PHCY 411: Basic Pharmaceutics II
MOPH 862: Advanced Physical Pharmacy
MOPH 864: Advanced Drug Delivery
MOPH 738: Nanomedicine
Polymeric Micelles for Drug Delivery: From Idea to Clinics, Nanotechnologies in Cancer Diagnosis, Therapy, and Prevention. The New York Academy of Sciences, New York, NY, June 12, 2013.
Nanomedicine—Time to Collect Stones: From Science Fiction to Clinical Practice (Russian). Festival of Science (Festival Nauki), Moscow, Oct. 14, 2012.
Honors and Awards
2013: Academia Europaea (The Academy of Europe)
2010: 2010 Russian MegaGrant
1995: NSF CAREER Award